PI Industries Ltd (NSE:PIIND)
₹ 2,751.6 -23 (-0.83%) Market Cap: 420.92 Bil Enterprise Value: 389.32 Bil PE Ratio: 31.61 PB Ratio: 3.72 GF Score: 86/100

Q1 2025 PI Industries Ltd Earnings Call Transcript

Aug 08, 2024 / 08:30AM GMT
Release Date Price: ₹4457.25 (+0.79%)

Key Points

Positve
  • Revenue increased by 28% in Q1-FY25, driven mainly by exports.
  • Agchem export revenue grew by 14%, with a 24% increase in volume for new products.
  • Domestic revenue saw a strong growth of 39% year-on-year.
  • Profit margins improved due to a favorable product mix and higher share of biological products.
  • Cash flow from operating activities increased by 103% to INR 6,145 million.
Negative
  • Profit after tax decreased by 17% to INR 4,488 million.
  • Domestic revenue declined by 8% to INR 3,195 million.
  • Pharma segment experienced a PBT loss of INR 70 crore due to deferred revenues.
  • Effective tax rate increased to 20.7% from 14% in the previous year.
  • Inventory levels remain high, impacting immediate business performance.
Operator

Ladies and gentlemen, good day, and welcome to the Q1-FY25 earnings conference call of PI Industries Limited. (Operator Instructions)

I now hand the conference over to Mr. Nishid Solanki from CDR India. Thank you, and over to you, sir.

Nishid Solanki
CDR India Pvt Ltd. - IR

Thank you. Good afternoon, everyone, and thank you for joining us on PI Industries Q1-FY25 earnings conference call. Today, we are joined by senior members of the management team, including Mr. Mayank Singhal, Executive Vice Chairman and Managing Director; Mr. Rajnish Sarna, Joint Managing Director; Mr. Manikantan Viswanathan, Chief Financial Officer; Mr. Prashant Hegde, CEO, Domestic; and Mr. Atul Gupta, CEO, Exports. We will begin the call with key perspectives from Mr. Singhal. After that, we will have Mr. Manikantan sharing his views on the company's financial performance. Thereafter, the forum will be open for question-and-answer session.

Before we begin, I would like to underline that certain statements made on today's conference call may be forward-looking in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot